These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22249335)

  • 1. Suberoylanilide hydroxamic acid affects γH2AX expression in osteosarcoma, atypical teratoid rhabdoid tumor and normal tissue cell lines after irradiation.
    Blattmann C; Oertel S; Thiemann M; Weber KJ; Schmezer P; Zelezny O; Lopez Perez R; Kulozik AE; Debus J; Ehemann V
    Strahlenther Onkol; 2012 Feb; 188(2):168-76. PubMed ID: 22249335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of radiation response in osteosarcoma and rhabdomyosarcoma cell lines by histone deacetylase inhibition.
    Blattmann C; Oertel S; Ehemann V; Thiemann M; Huber PE; Bischof M; Witt O; Deubzer HE; Kulozik AE; Debus J; Weber KJ
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):237-45. PubMed ID: 20646843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model.
    Thiemann M; Oertel S; Ehemann V; Weichert W; Stenzinger A; Bischof M; Weber KJ; Perez RL; Haberkorn U; Kulozik AE; Debus J; Huber PE; Battmann C
    Radiat Oncol; 2012 Mar; 7():52. PubMed ID: 22458853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of suberoylanilide hydroxamic acid with heavy ion therapy shows promising effects in infantile sarcoma cell lines.
    Oertel S; Thiemann M; Richter K; Weber KJ; Huber PE; Perez RL; Brons S; Bischof M; Kulozik AE; Ehemann V; Debus J; Blattmann C
    Radiat Oncol; 2011 Sep; 6():119. PubMed ID: 21933400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status.
    Folkvord S; Ree AH; Furre T; Halvorsen T; Flatmark K
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):546-52. PubMed ID: 19427556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair.
    Lee JH; Choy ML; Ngo L; Foster SS; Marks PA
    Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14639-44. PubMed ID: 20679231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitization of glioblastoma cells using a histone deacetylase inhibitor (SAHA) comparing carbon ions with X-rays.
    Barazzuol L; Jeynes JC; Merchant MJ; Wéra AC; Barry MA; Kirkby KJ; Suzuki M
    Int J Radiat Biol; 2015 Jan; 91(1):90-8. PubMed ID: 25040548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between chromatin structure and sensitivity to molecularly targeted auger electron radiation therapy.
    Terry SY; Vallis KA
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1298-305. PubMed ID: 22336201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of radiation response by histone deacetylase inhibition.
    Chinnaiyan P; Vallabhaneni G; Armstrong E; Huang SM; Harari PM
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):223-9. PubMed ID: 15850925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suberoylanilide hydroxyamic acid modification of chromatin architecture affects DNA break formation and repair.
    Singh S; Le H; Shih SJ; Ho B; Vaughan AT
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):566-73. PubMed ID: 20117292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of rapamycin and SAHA enhanced radiosensitization by inducing autophagy and acetylation in NSCLC.
    Wang Y; Liu F; Fang C; Xu L; Chen L; Xu Z; Chen J; Peng W; Fu B; Li Y
    Aging (Albany NY); 2021 Jul; 13(14):18223-18237. PubMed ID: 34321364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vorinostat enhances the radiosensitivity of a breast cancer brain metastatic cell line grown in vitro and as intracranial xenografts.
    Baschnagel A; Russo A; Burgan WE; Carter D; Beam K; Palmieri D; Steeg PS; Tofilon P; Camphausen K
    Mol Cancer Ther; 2009 Jun; 8(6):1589-95. PubMed ID: 19509253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci.
    Munshi A; Tanaka T; Hobbs ML; Tucker SL; Richon VM; Meyn RE
    Mol Cancer Ther; 2006 Aug; 5(8):1967-74. PubMed ID: 16928817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitors suppress the growth of human osteosarcomas in vitro and in vivo.
    Wu Z; Ma C; Shan Z; Ju Y; Li S; Zhao Q
    J BUON; 2013; 18(4):1032-7. PubMed ID: 24344034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitization by histone deacetylase inhibition in an osteosarcoma mouse model.
    Blattmann C; Thiemann M; Stenzinger A; Christmann A; Roth E; Ehemann V; Debus J; Kulozik AE; Weichert W; Huber PE; Oertel S; Abdollahi A
    Strahlenther Onkol; 2013 Nov; 189(11):957-66. PubMed ID: 23801068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy.
    Blattmann C; Oertel S; Thiemann M; Dittmar A; Roth E; Kulozik AE; Ehemann V; Weichert W; Huber PE; Stenzinger A; Debus J
    Radiat Oncol; 2015 Jul; 10():146. PubMed ID: 26178881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiosensitization by the histone deacetylase inhibitor PCI-24781.
    Banuelos CA; Banáth JP; MacPhail SH; Zhao J; Reitsema T; Olive PL
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6816-26. PubMed ID: 18006784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-responsive gene expression in suberoylanilide hydroxamic acid-treated resting CD4+ T cells.
    Reardon B; Beliakova-Bethell N; Spina CA; Singhania A; Margolis DM; Richman DR; Woelk CH
    AIDS; 2015 Nov; 29(17):2235-44. PubMed ID: 26258524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suberoylanilide hydroxamic acid radiosensitizes tumor hypoxic cells in vitro through the oxidation of nitroxyl to nitric oxide.
    Samuni Y; Wink DA; Krishna MC; Mitchell JB; Goldstein S
    Free Radic Biol Med; 2014 Aug; 73():291-8. PubMed ID: 24880052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid.
    Camphausen K; Cerna D; Scott T; Sproull M; Burgan WE; Cerra MA; Fine H; Tofilon PJ
    Int J Cancer; 2005 Apr; 114(3):380-6. PubMed ID: 15578701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.